You are here

Article Text

Article menu

Download PDFPDF

Poster Presentation
P17. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells
  1. M Schnurr1,
  2. A Steger2,
  3. H Lohr2,
  4. H Bourhis2,
  5. S Endres2 and
  6. P Duewell2
  1. Aff1 Division of Clinical Pharmacology Munich Germany
  2. Aff2 grid.5252.0000000041936973XLMU Munich, Division of Clinical Pharmacology Munich Germany

https://doi.org/10.1186/2051-1426-2-S2-P8

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Meeting abstracts

    Background

    We recently identified RIG-I-like helicases (RLH) as therapeutic targets of pancreatic cancer for counteracting immunosuppressive mechanisms and apoptosis induction. Here, we investigated immunogenic consequences of RLH-induced tumour cell death.

    Material and methods

    Murine pancreatic cancer cells (Panc02) were treated with RLH ligands to induce apoptosis and were then cocultured with primary dendritic cells (DC). DC maturation marker expression, antigen uptake and antigen cross-presentation were assessed.

    Results

    RLH ligands induced production of type I IFN, HMGB1 and Hsp70 and translocation of calreticulin to the outer cell membrane of tumour cells. In cocultures, DC upregulated B7 expression, which was mediated by tumour-derived type I IFN, whereas TLR, RAGE or inflammasome signaling was dispensable. CD8a+ DC effectively engulfed apoptotic tumour material and cross-presented tumour-associated antigen to naïve CD8+ T cells. In comparison, tumour cell death mediated by oxaliplatin, staurosporine or mechanical disruption failed to induce DC activation, antigen uptake or cross-presentation. Moreover, tumour cells treated with sublethal doses of RLH ligands upregulated MHC-I and Fas expression and were sensitised towards CTL- and Fas-mediated killing.

    Conclusions

    RLH ligands induce a highly immunogenic form of tumour cell death linking innate and adaptive immunity.